THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Clinique La Prairie Partners with Zora Biosciences on CERT2 Testing

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Zora Biosciences supplies the CERT2 ceramide-based cardiovascular risk assessment, which Clinique La Prairie identifies as an innovative test offered by the clinic.

Current status
Official collaboration
Known availability
The published source describes the collaboration; timing details remain under review.
Place
International, International
Source checked
September 18, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.